Takeda's Investigational Compound SYR-322 for Treatment of ...

Takeda's Investigational Compound SYR-322 for Treatment of ...
Japan Corporate News (press release), Japan - 9 hours agoSYR-322 is one of the DPP4 inhibitors for the treatment of type 2 diabetes discovered by one of Takeda's subsidiaries in the US, Takeda San Diego, Inc. ...

The Road to Diabetes
Diabetes Interview, CA - 20 hours agoThe development and progression of diabetes is slow and insidious. ... The first four stages are milestones on the road to diabetes. ...

Lifestyle changes may reduce risk of diabetes, says study
Hindu, India - Jan 19, 2006CHENNAI: Even small modifications in diet and exercise can reduce the risk of diabetes, according to a study by the Diabetes Research Centre and MV Hospital ...

Rise in aspirin use seen among US adults
Reuters - Jan 19, 2006... The proportion among those with cardiovascular disease (CVD) and diabetes was even higher - 82.8 and 62.6 percent, respectively. ...